Average Co-Inventor Count = 10.59
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Methylgene, Inc. (3 from 53 patents)
2. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
3. Envivo Pharmaceuticals, Inc. (1 from 13 patents)
4. Forum Pharmaceuticals, Inc. (1 from 9 patents)
5. Msd Italia S.r.l. (1 from 7 patents)
6. Merck Canada Inc. (40 patents)
4 patents:
1. 9328138 - HCV NS3 protease inhibitors
2. 9193749 - Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
3. 8673911 - Inhibitors of histone deacetylase
4. 8399452 - Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors